Philip Gorelick

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. doi request reprint Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Chicago, Illinois, USA
    Ann N Y Acad Sci 1207:155-62. 2010
  2. doi request reprint Advances in vascular cognitive impairment 2007
    Philip B Gorelick
    Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood Street Room 855N, Chicago, Illinois 60612, USA
    Stroke 39:279-82. 2008
  3. doi request reprint Challenges of designing trials for the primary prevention of stroke
    Philip B Gorelick
    Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood Street, Room 855N, Chicago, IL 60612, USA
    Stroke 40:S82-4. 2009
  4. doi request reprint Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier
    Philip B Gorelick
    Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago, IL 60612, USA
    Stroke 39:2396-9. 2008
  5. doi request reprint Lipoprotein-associated phospholipase A2 and risk of stroke
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois at Chicago College of Medicine, 912 South Wood Street, Chicago, IL 60612, USA
    Am J Cardiol 101:34F-40F. 2008
  6. ncbi request reprint Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation?
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Illinois 60612, USA
    Stroke 38:1652-4. 2007
  7. ncbi request reprint Life after ESPRIT: which first-line antiplatelet treatment should we use?
    Philip B Gorelick
    Department of Neurology and Rehabilitation, Center for Stroke Research, University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
    Int J Stroke 2:40-2. 2007
  8. ncbi request reprint The burden and management of TIA and stroke in government-funded healthcare programs
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago, 912 S Wood St, IL 60612, USA
    Am J Manag Care 15:S177-84. 2009
  9. ncbi request reprint William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Chicago, Ill 60612, USA
    Stroke 36:875-9. 2005
  10. ncbi request reprint IMAGES and FAST-MAG: magnesium for acute ischaemic stroke
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Illinois, USA
    Lancet Neurol 3:330. 2004

Research Grants

  1. AFRICAN AMERICAN ANTIPLATELET STROKE PREVENTION STUDY
    Philip Gorelick; Fiscal Year: 2004
  2. RISK MARKERS FOR DEMENTIA AFTER STROKE
    Philip Gorelick; Fiscal Year: 2003
  3. AFRICAN AMERICAN ANTIPLATELET STROKE PREVENTION STUDY
    Philip Gorelick; Fiscal Year: 1999

Detail Information

Publications62

  1. doi request reprint Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Chicago, Illinois, USA
    Ann N Y Acad Sci 1207:155-62. 2010
    ..NSAIDs hold promise to prevent dementia if given in an appropriate time window during the induction phase of dementia and to subjects with apolipoprotein E (APOE) e4 alleles. Also, immunotherapy may prove beneficial...
  2. doi request reprint Advances in vascular cognitive impairment 2007
    Philip B Gorelick
    Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood Street Room 855N, Chicago, Illinois 60612, USA
    Stroke 39:279-82. 2008
  3. doi request reprint Challenges of designing trials for the primary prevention of stroke
    Philip B Gorelick
    Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood Street, Room 855N, Chicago, IL 60612, USA
    Stroke 40:S82-4. 2009
    ..Summary of Review- We discuss prevention of first stroke in the context of clinical trial design in the ARRIVE trial and a primary prevention trial in development for the elderly...
  4. doi request reprint Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier
    Philip B Gorelick
    Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago, IL 60612, USA
    Stroke 39:2396-9. 2008
    ..Large artery intracranial occlusive disease (LAICOD) is a common and important stroke subtype. In this commentary, we review key epidemiological aspects of LAICOD...
  5. doi request reprint Lipoprotein-associated phospholipase A2 and risk of stroke
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois at Chicago College of Medicine, 912 South Wood Street, Chicago, IL 60612, USA
    Am J Cardiol 101:34F-40F. 2008
    ..Therefore, Lp-PLA(2) determination may provide a pivotal opportunity to appropriately classify previously misclassified persons who are actually at high risk of stroke and in need of aggressive stroke intervention...
  6. ncbi request reprint Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation?
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Illinois 60612, USA
    Stroke 38:1652-4. 2007
  7. ncbi request reprint Life after ESPRIT: which first-line antiplatelet treatment should we use?
    Philip B Gorelick
    Department of Neurology and Rehabilitation, Center for Stroke Research, University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
    Int J Stroke 2:40-2. 2007
  8. ncbi request reprint The burden and management of TIA and stroke in government-funded healthcare programs
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago, 912 S Wood St, IL 60612, USA
    Am J Manag Care 15:S177-84. 2009
    ....
  9. ncbi request reprint William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, Chicago, Ill 60612, USA
    Stroke 36:875-9. 2005
    ..Vascular risk factors are common in the elderly, and some such as hypertension may be important predictors of cognitive impairment...
  10. ncbi request reprint IMAGES and FAST-MAG: magnesium for acute ischaemic stroke
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine, Illinois, USA
    Lancet Neurol 3:330. 2004
  11. ncbi request reprint Risk factors for vascular dementia and Alzheimer disease
    Philip B Gorelick
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 South Wood St, Room 855N, Chicago, IL 60612, USA
    Stroke 35:2620-2. 2004
    ..We review vascular factors that might be responsible to cognitive decline in Alzheimer disease and vascular cognitive impairment and the corresponding interventions that might prevent cognitive impairment as we age...
  12. ncbi request reprint Risk of hemorrhagic stroke with aspirin use: an update
    Philip B Gorelick
    University of Illinois, Chicago, USA
    Stroke 36:1801-7. 2005
    ..This review provides an update of the available data to offer greater clarity regarding the risks of aspirin with respect to hemorrhagic stroke, as well as insights regarding patient selection to minimize the risk of this complication...
  13. ncbi request reprint Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial
    Philip B Gorelick
    Department of Neurologic Sciences, Rush Medical College, Chicago, IL 60612, USA
    JAMA 289:2947-57. 2003
    ..Blacks are disproportionately affected by stroke, and they are about 2 times more likely than most other individuals in the United States to die of or experience stroke...
  14. ncbi request reprint Epidemiology of transient ischemic attack and ischemic stroke in patients with underlying cardiovascular disease
    Philip B Gorelick
    Center for Stroke Prevention, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Clin Cardiol 27:II4-11. 2004
    ..Antiplatelet therapy and administration of oral anticoagulants have both been shown to have a substantial impact on stroke in specified populations at risk...
  15. ncbi request reprint Evolving perspectives on clopidogrel in the treatment of ischemic stroke
    Philip Gorelick
    Department of Neurology and Center for Stroke Research, University of Illinois College of Medicine at Chicago, USA
    J Cardiovasc Pharmacol Ther 11:245-8. 2006
    ..On the basis of the current totality of evidence for long-term treatment of survivors of ischemic stroke or TIA, clopidogrel is an effective alternative for patients who are intolerant to aspirin...
  16. ncbi request reprint Diagnosis and management of vascular cognitive impairment
    David L Nyenhuis
    Department of Neurology and Rehabilitation Medicine, University of Illinois at Chicago, Center for Stroke Research, 1645 West Jackson Boulevard, Suite 400, Chicago, IL 60612, USA
    Curr Atheroscler Rep 9:326-32. 2007
    ..Future clinical trials should concentrate on both primary risk factor control and development of new therapeutic agents to treat patients already diagnosed with VCI...
  17. ncbi request reprint New approaches to stroke prevention in atrial fibrillation
    Fernando D Testai
    Section of Cerebrovascular Disease and Neurologic Critical Care, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 South Wood Street, Room 855N, Chicago, IL, 60612, USA
    Curr Treat Options Cardiovasc Med 12:261-73. 2010
    ..However, the use of warfarin may be challenging in some patients, and there is a need for alternative treatments. We describe alternative treatments for AF and provide an overview on emerging therapies...
  18. ncbi request reprint Stroke in Black Americans
    Sean Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, 912 S Wood Street, Room 855N, mailcode 796, Chicago, IL 60612, USA
    Curr Cardiol Rep 7:29-33. 2005
    ..Therefore, our knowledge regarding stroke in black Americans is somewhat limited. This article provides an update on developments in our understanding regarding stroke in this at-risk population...
  19. pmc Effect of sex on outcome after recurrent stroke in African Americans: results from the African American Antiplatelet Stroke Prevention Study
    Fernando D Testai
    Department of Neurology and Rehabilitation, Section of Cerebrovascular Disease and Neurological Critical Care, University of Illinois College of Medicine at Chicago, Chicago, IL 60612, USA
    J Stroke Cerebrovasc Dis 19:321-5. 2010
    ..Our objective was to investigate the effect of sex on the outcome of recurrent nonfatal stroke in the African American Antiplatelet Stroke Prevention Study (AAASPS)...
  20. doi request reprint Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders
    Fernando D Testai
    Department of Neurology and Rehabilitation, Section of Cerebrovascular Disease and Neurological Critical Care, University of Illinois College of Medicine at Chicago, 912 S Wood Street, Chicago, IL 60612, USA
    Arch Neurol 67:148-53. 2010
    ..In part 2, we overview homocystinuria, organic acidurias, and urea cycle disorders...
  21. ncbi request reprint Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS
    Sean Ruland
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, 60612, USA
    Arch Neurol 62:386-90. 2005
    ..The rates of obesity and the metabolic syndrome and the impact on traditional vascular risk factors in African American stroke survivors are unknown...
  22. ncbi request reprint Epidemiology of stroke in African Americans and Hispanic Americans
    Dilip K Pandey
    Center for Stroke Research, University of Illinois College of Medicine, Chicago, IL 60612, USA
    Med Clin North Am 89:739-52, vii. 2005
    ..These two groups have been chosen for review and discussion because the available epidemiologic databases are relatively broad, and the authors have personal experience in the conduct of research studies in these populations...
  23. doi request reprint Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes
    Fernando D Testai
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood St, Room 855N NPI
    Arch Neurol 67:19-24. 2010
    ..In part 1, we concentrate on Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. In part 2 we will review homocystinuria, organic acidurias, and urea cycle disorders...
  24. ncbi request reprint Prevention of stroke recurrence
    Philip B Gorelick
    Department of Neurological Sciences, Rush Medical College, Chicago, Illinois 60612, USA
    Int Psychogeriatr 15:167-71. 2003
    ..In this article we review standard and more novel means to prevent stroke recurrence...
  25. ncbi request reprint Update on the management of hypertension to prevent stroke
    Laura Pedelty
    Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 South Wood Street, Room 855N, Chicago, IL 60612, USA
    Curr Treat Options Neurol 8:486-95. 2006
    ..Further studies are needed to ascertain the mechanisms of benefit of different classes of antihypertensive agents in the reduction of stroke and cardiovascular disease risk...
  26. doi request reprint Management of hypertension and cerebrovascular disease in the elderly
    Laura Pedelty
    Department of Neurology, University of Illinois at Chicago Circle, Chicago, Illinois 60612, USA
    Am J Med 121:S23-31. 2008
    ..Several clinical trials currently in progress promise to provide guidance regarding the optimal choice of agent and degree of blood pressure lowering for prevention of stroke and cognitive decline in elderly patients...
  27. ncbi request reprint The pattern of neuropsychological deficits in Vascular Cognitive Impairment-No Dementia (Vascular CIND)
    David L Nyenhuis
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, IL 60612, USA
    Clin Neuropsychol 18:41-9. 2004
    ..This cognitive and behavioral pattern similarity supports the hypothesis that Vascular CIND lies on a continuum between NCI and VaD...
  28. ncbi request reprint Predictors of survival in African American patients with AD, VaD, or stroke without dementia
    Sally Freels
    Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612 4336, USA
    Neurology 59:1146-53. 2002
    ..A hospital-based cohort of African American patients in the Chicago area with AD, vascular dementia (VaD), or stroke without dementia (SWD) were followed for up to 7 years...
  29. ncbi request reprint Cognitive and functional decline in African Americans with VaD, AD, and stroke without dementia
    David L Nyenhuis
    Center for Stroke Research, Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Neurology 58:56-61. 2002
    ....
  30. ncbi request reprint Chronic management of blood pressure after stroke
    Laura Pedelty
    Department of Neurology and Rehabilitation, University of Illinois at Chicago, Neuropsychiatric Institute North Tower, 912 South Wood Street MC 796, Chicago, IL 60612, USA
    Hypertension 44:1-5. 2004
  31. pmc Are there differences in risk factor profiles and frequency of CT/MRI-based infarcts among African American stroke patients with and without hypertension? A report from the African American Antiplatelet Stroke Prevention Study (AAASPS)
    Chandra Y Whittley
    Departments of Neurological Science and Preventive Medicine, Rush Medical College, Chicago, Illinois 60612, USA
    J Natl Med Assoc 95:423-32. 2003
    ..BACKGROUND; African Americans (AAs) have a high risk of stroke and a high prevalence of cardiovascular risk factors. Little is known about stroke risk profiles among non-hypertensive AAs...
  32. pmc Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design
    Sepideh Amin-Hanjani
    Department of Neurosurgery, Neuropsychiatric Institute, University of Illinois at Chicago, Chicago, IL 60612 5970, USA
    Int J Stroke 5:499-505. 2010
    ..Preliminary studies indicate that stroke risk in vertebrobasilar disease is strongly related to haemodynamic compromise, which can be measured noninvasively using quantitative magnetic resonance angiography...
  33. doi request reprint Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
    Michael H Davidson
    Preventive Cardiology Center, Pritzker School of Medicine, University of Chicago, 515 North State Street, Chicago, IL 60610, USA
    Am J Cardiol 101:51F-57F. 2008
    ..However, at this time Lp-PLA(2) cannot be recommended as a target of therapy...
  34. ncbi request reprint The Black Seventh-Day Adventist exploratory health study
    David L Nyenhuis
    Psychology Department, Center for Stroke Research, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Ethn Dis 13:208-12. 2003
    ..The Black SDA community represents a unique opportunity to test the effects of diet, lifestyle, and spirituality on risk for stroke and dementia...
  35. ncbi request reprint Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration
    Anaadriana Zakarija
    VA Chicago Healthcare System, VA Midwest Center for Health Services and Policy Research, Division of Hematology Oncology, Department of Medicine, Northwestern University Medical Center, Chicago, Ill, USA
    Stroke 35:533-7. 2004
    ....
  36. ncbi request reprint North American perspective of antiplatelet agents
    Philip B Gorelick
    Department of Neurosciences, Rush Medical College, Chicago, Illinois, USA
    Adv Neurol 92:281-91. 2003
  37. doi request reprint Gray matter atrophy in patients with ischemic stroke with cognitive impairment
    Glenn T Stebbins
    Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison, Suite 309, Chicago, IL 60612, USA
    Stroke 39:785-93. 2008
    ..The present study investigated regional gray matter volume differences between patients with ischemic stroke with no cognitive impairment and those with impairment in at least one domain of cognitive function...
  38. doi request reprint Cardiovascular protection for all individuals at high risk: evidence-based best practice
    George Bakris
    Department of Medicine, Hypertensive Diseases Unit, University of Chicago Pritzker School of Medicine, Chicago, IL, USA
    Clin Res Cardiol 97:713-25. 2008
    ....
  39. ncbi request reprint New horizons for stroke prevention: PROGRESS and HOPE
    Philip B Gorelick
    Department of Neurolgoy, Rush Medical College, Chicago, IL 60612, USA
    Lancet Neurol 1:149-56. 2002
    ..The PROGRESS and HOPE trials have shown that ACE inhibitors have an important role in the prevention of stroke and cardiovascular-disease events...
  40. ncbi request reprint Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review
    Philip B Gorelick
    Department of Neurologic Sciences, Rush Medical College, Chicago, Ill, USA
    Stroke 33:862-75. 2002
    ..As such, the vulnerable atherosclerotic plaque has become the main focus for new medical strategies for plaque stabilization and stroke prevention...
  41. ncbi request reprint TIA incidence and prevalence: the Stroke Belt perspective
    Philip B Gorelick
    Department of Neurology, University of Illinois College of Medicine, Chicago, IL 60612, USA
    Neurology 62:S12-4. 2004
  42. ncbi request reprint Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Sean Ruland
    Center for Stroke Research and Section of Cerebrovascular Disease and Neurological Critical Care, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson, Suite 400, Chicago, IL 60612, USA
    Curr Neurol Neurosci Rep 3:21-6. 2003
    ..We review the mounting evidence that suggests that statins and ACE inhibitors have so-called pleiotropic effects that may lead to stroke prevention...
  43. ncbi request reprint Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    Sean Ruland
    Center for Stroke Research and Section of Cerebrovascular Disease and Neurological Critical Care, Department of Neurological Sciences, Rush Medical College, 1645 West Jackson, Suite 400, Chicago, IL 60612, USA
    Curr Atheroscler Rep 5:38-43. 2003
    ..We review the mounting evidence that suggests that statins and ACE inhibitors have so-called pleiotropic effects that may lead to stroke prevention...
  44. ncbi request reprint Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities
    Sean Ruland
    Department of Neurological Sciences, Section of Cerebrovascular Disease and Neurologic Critical Care, Rush Medical College, Chicago, Ill 60612, USA
    Stroke 33:1334-9. 2002
    ..To define areas for quality improvement in acute stroke care, a statewide assessment of preparedness for acute stroke diagnosis and treatment was carried out among 202 acute receiving hospitals in Illinois...
  45. ncbi request reprint Longitudinal changes in white matter following ischemic stroke: a three-year follow-up study
    Changsheng Wang
    Department of Neurological Sciences, Rush University Medical Center, Room 341B, 1735 West Harrison Street, Chicago, IL 60612, USA
    Neurobiol Aging 27:1827-33. 2006
    ..These results demonstrate a long-term improvement in apparent white matter integrity following ischemic stroke that continues, at least, into the second year following the insult...
  46. pmc Stroke risk factor profiles in African American women: an interim report from the African-American Antiplatelet Stroke Prevention Study
    Bradford B Worrall
    Department of Neurology, University of Virginia, Charlottesville, 22908, USA
    Stroke 33:913-9. 2002
    ..The purpose of this study was to determine whether medical and lifestyle factors differ among women and men who have enrolled in the African-American Antiplatelet Stroke Prevention Study (AAASPS)...
  47. ncbi request reprint Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease
    Barbara G Vickrey
    RAND, Santa Monica, Calif, USA
    Stroke 33:901-6. 2002
    ..We estimated the occurrence of secondary stroke, acute myocardial infarction (AMI), and vascular deaths among 2 large, managed care samples...
  48. ncbi request reprint Blood pressure control in stroke patients: what should the consulting neurologist advise?
    Franz H Messerli
    Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA 70121, USA
    Neurology 59:23-5. 2002
  49. ncbi request reprint Converging pathogenic mechanisms in vascular and neurodegenerative dementia
    Costantino Iadecola
    Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10021, USA
    Stroke 34:335-7. 2003
  50. ncbi request reprint Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction
    Askiel Bruno
    Indiana University School of Medicine, Indianapolis, USA
    Stroke 35:727-30. 2004
    ..This pilot study was intended to evaluate the reproducibility of urinary 11-DTB2 over time and to look for evidence of aspirin resistance...
  51. ncbi request reprint Plasma thrombosis markers following cerebral infarction in African Americans
    Askiel Bruno
    Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 292, Indianapolis, IN 46202 5111, USA
    Thromb Res 115:73-7. 2005
  52. ncbi request reprint Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials
    William B White
    Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA
    Am J Cardiol 99:91-8. 2007
    ..In conclusion, these analyses failed to demonstrate an increased CV risk with celecoxib relative to placebo and demonstrated a comparable rate of CV events with celecoxib treatment compared with nonselective NSAIDs...
  53. ncbi request reprint Reduction of stroke risk factors
    John B Kostis
    J Clin Hypertens (Greenwich) 9:49-56. 2007
    ..Also participating were Philip B. Gorelick, MD, MPH, Director, Center for Stroke Research, University of Illinois College of Medicine, Chicago, IL, and Franz H. Messerli, MD, St Luke's-Roosevelt Hospital Center, New York, NY...
  54. ncbi request reprint Vascular cognitive impairment
    John T O'Brien
    Institute for Aging and Health, Newcastle General Hospital, Newcastle upon Tyne, UK
    Lancet Neurol 2:89-98. 2003
    ..Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment...
  55. ncbi request reprint Advances in vascular cognitive impairment 2006
    John V Bowler
    Royal Free Hospital and University College London, Department of Neurology, Royal Free Hospital, London, UK
    Stroke 38:241-4. 2007
  56. ncbi request reprint Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditions
    Elizabeth M Sloss
    RAND Corp, Santa Monica, Calif, USA
    Cerebrovasc Dis 18:8-15. 2004
    ..The cost of acute ischemic events in persons with established atherosclerotic conditions is unknown...
  57. ncbi request reprint Establishing data elements for the Paul Coverdell National Acute Stroke Registry: Part 1: proceedings of an expert panel
    Wendy A Wattigney
    Centers for Disease Control and Prevention, Atlanta, GA 30341 3717, USA
    Stroke 34:151-6. 2003
    ..An expert panel was convened by the Centers for Disease Control and Prevention to recommend a standard list of data elements to be considered during development of prototypes of the Paul Coverdell National Acute Stroke Registry...
  58. ncbi request reprint Hypertension, angiotensin, and stroke: beyond blood pressure
    Costantino Iadecola
    Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10021, USA
    Stroke 35:348-50. 2004
  59. ncbi request reprint Posterior thalamic hemorrhage induces "pusher syndrome"
    Jose C Masdeu
    Neurology 65:1682; author reply 1682. 2005
  60. ncbi request reprint Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Counc
    Larry B Goldstein
    Stroke 37:1583-633. 2006
    ..This guideline provides an overview of the evidence on various established and potential stroke risk factors and provides recommendations for the reduction of stroke risk...
  61. ncbi request reprint Uncertainty of management of blood pressure and lipids in the elderly: time for a primary prevention trial
    Philip B Gorelick
    Stroke 38:212-3. 2007
  62. ncbi request reprint Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Counc
    Larry B Goldstein
    Circulation 113:e873-923. 2006
    ..This guideline provides an overview of the evidence on various established and potential stroke risk factors and provides recommendations for the reduction of stroke risk...

Research Grants19

  1. AFRICAN AMERICAN ANTIPLATELET STROKE PREVENTION STUDY
    Philip Gorelick; Fiscal Year: 2004
    ..They have currently completed two-thirds of the projected enrollment and should be able to continue to administer this trial competently to its conclusion. ..
  2. RISK MARKERS FOR DEMENTIA AFTER STROKE
    Philip Gorelick; Fiscal Year: 2003
    ..They state that refinement in our knowledge of mechanisms and causes for dementia in stroke patients may lead to an improvement in prevention and treatment strategies. ..
  3. AFRICAN AMERICAN ANTIPLATELET STROKE PREVENTION STUDY
    Philip Gorelick; Fiscal Year: 1999
    ..Furthermore, the study could also serve as an organizational framework for future studies of stroke prevention or hyperacute treatment in the Chicago area. ..